Results 111 to 120 of about 101,889 (202)

Real-life comparison of posaconazole versus fluconazole for primary antifungal prophylaxis during remission-induction chemotherapy for acute leukemia. [PDF]

J Assoc Med Microbiol Infect Dis Can, 2023
Dufresne SF, Bergeron J, Beauchemin S, Abou Chakra CN, Vadnais B, Bouchard P, Labbé AC, Laverdière M.   +7 more
europepmc   +1 more source

Response-guided induction therapy in pediatric acute myeloid leukemia with excellent remission rate

, 2011
Purpose: To evaluate the early treatment response in children with acute myeloid leukemia (AML) using a response-guided induction strategy that includes idarubicin in the first course.
Abrahamsson, Jonas, Zeller, B, Jónsson, Olafur G., Birgitte Lausen, Josefine Palle, Abrahamsson, J, Hasle, Henrik,, Jonsson, Olafur G, Erik Forestier, Palle, Josefine,, Hasle, Henrik, Forestier, Erik, Henrik Hasle, Lausen, Birgitte, Abrahamsson, Jonas,, Jesper Heldrup, Jahnukainen, K,, Forestier, E, Palle, J, Jahnukainen, Kirsi, Jonas Abrahamsson, Lausen, B, Jónsson, OG, Forestier, Erik,, Hasle, H, Heldrup, Jesper, Kirsi Jahnukainen, Bernward Zeller, Palle, Josefine, Zeller, Bernward, Ólafur G. Jónsson, Heldrup, J   +31 more
core   +1 more source

Feasibility of azacitidine added to standard chemotherapy in older patients with acute myeloid leukemia - a randomised SAL pilot study

, 2012
INTRODUCTION: Older patients with acute myeloid leukemia (AML) experience short survival despite intensive chemotherapy. Azacitidine has promising activity in patients with low proliferating AML.
Ulrich Dührsen, Anja Koschmieder (106749), Matthias Stelljes, Christian Thiede (106768), Carsten Müller-Tidow, Nicola Tidow (106758), Noppeney, Richard, Utz Krug, Gerhard Ehninger, Daniela Schwammbach (106754), Steffen Koschmieder, Nicola Tidow, Wolfgang E Berdel, Markus Schaich (106764), Stelljes, Matthias, Matthias Stelljes (106772), Utz Krug (106744), Carsten Müller-Tidow (105305), Krug, Utz, Tidow, Nicola, Bug, Gesine, Schaich, Markus, Björn Steffen, Richard Noppeney (106769), Gerss, Joachim, Christian Thiede, Joachim Gerss, Schwammbach, Daniela, Thomas Büchner, Björn Steffen (106759), Büchner, Thomas, Ulrich Dührsen (106782), Anja Koschmieder, Christoph Röllig, Steffen, Björn, Markus Schaich, Steffen Koschmieder (106779), Thomas Büchner (106775), Hubert Serve, Koschmieder, Steffen, Christian H. Brandts (106762), Ehninger, Gerhard, Brandts, Christian Hubertus, Berdel, Wolfgang E., Joachim Gerss (106757), Gerhard Ehninger (106788), Dührsen, Ulrich, Wolfgang E. Berdel (106792), Richard Noppeney, Gesine Bug (106760), Serve, Hubert, Müller-Tidow, Carsten, Daniela Schwammbach, Christian H Brandts, Hubert Serve (106786), Thiede, Christian, Gesine Bug, Koschmieder, Anja, Röllig, Christoph, Christoph Röllig (106766)   +59 more
core   +1 more source

Real-world-data on efficacy and safety of topical budesonide therapy (orodispersible tablet) in induction and maintenance therapy in adult patients with active eosinophilic esophagitis

Therapeutic Advances in Gastroenterology
Background: Eosinophilic esophagitis (EoE) is a chronic, progressive, immune-mediated disease of the esophagus. Esophageal dysfunction in solid food dysphagia combined with eosinophil-dominant inflammation (⩾15 eos/high-power-field (hpf)) serves as ...
Maja Weisfeld, Stephan Miehlke, Silke Meszaros, Verena Keitel-Anselmino, Ulrike von Arnim   +4 more
doaj   +1 more source

PLEX in AAV-GN: insights from the meta-analysis results and impact on remission induction treatment recommendations. [PDF]

Clin Kidney J, 2023
Casal Moura M, Crowson CS, Specks U, Warrington KJ, Zand L, Sethi S, Fervenza FC.   +6 more
europepmc   +1 more source

Safety and effectiveness of mepolizumab therapy in remission induction therapy for eosinophilic granulomatosis with polyangiitis: a retrospective study. [PDF]

Arthritis Res Ther, 2022
Ueno M, Miyagawa I, Aritomi T, Kimura K, Iwata S, Hanami K, Fukuyo S, Kubo S, Miyazaki Y, Nakayamada S, Tanaka Y.   +10 more
europepmc   +1 more source

Rituximab for Remission Induction and Maintenance in Refractory Systemic Lupus Erythematosus

, 2020
Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease with high morbidity if untreated. Sometimes, despite aggressive treatments, the disease remains active with cumulative organic damage.
Andres Mauricio Castro, Evelyn Muñoz-Buitrón, Carlos A Cañas, Mercedes Andrade Bejarano, Andrés F Echeverri, Fabio Bonilla-Abadía, Gabriel J Tobón, Nicolás Coronel Restrepo   +7 more
core  

Anti-neutrophil Cytoplasmic Antibody-negative Eosinophilic Granulomatosis with Polyangiitis Complicated with Peripheral Neuropathy that Underwent Remission Induction with Mepolizumab Monotherapy. [PDF]

Intern Med, 2023
Nishihara M, Suzuki M, Asatani S, Nagasawa Y, Tsukamoto M, Akiya K, Kobayashi H, Kitamura N, Nakamura H.   +8 more
europepmc   +1 more source

Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma. [PDF]

BMC Cancer, 2022
Wendler J, Fox CP, Valk E, Steinheber C, Fricker H, Isbell LK, Neumaier S, Okosun J, Scherer F, Ihorst G, Cwynarski K, Schorb E, Illerhaus G.   +12 more
europepmc   +1 more source

Adding low dose cyclophosphamide to rituximab for remission-induction may prolong relapse-free survival in patients with ANCA vasculitis: A retrospective study. [PDF]

J Transl Autoimmun, 2023
Ysermans R, Busch MH, Aendekerk JP, Damoiseaux JGMC, van Paassen P.   +4 more
europepmc   +1 more source